Literature DB >> 660280

Clinical evaluation of Tc-99m-diethyl-IDA in hepatobiliary disorders.

S Pauwels, M Steels, L Piret, C Beckers.   

Abstract

N,alpha(2,6-diethylacetanilide)-iminodiacetic acid is a new Tc-99m-labeled radiopharmaceutical primarily excreted through the biliary tract. Its high concentration in the bile allows the imaging of the biliary tree and the gallbladder. Scintigraphic studies were performed in 20 normal subjects and 42 patients suffering from various hepatobiliary disturbances. In normal subjects, the early liver uptake was followed by the accumulation of the tracer in the intrahepatic bile ducts and the gallbladder before its discharge into the duodenum. In cases of hepatocellar damage, the hepatic accumulation of the tracer was clearly depressed. Any acute or subacute disorder of the gallbladder was clearly demonstrated by Tc-99m-diethyl-IDA. In cases of asymptomatic cholelithiasis, we observed delayed visualization of the gallbladder associated with its decreased accumulation of the tracer. The intrahepatic bile ducts were distended in cases of incomplete obstruction of the hepatobiliary ducts, whereas they were never visualized when there was severe hepatocellular damage or complete obstruction of the biliary tree.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660280

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Association between false negative hepatobiliary scans and initial gallbladder visualization after 30 min.

Authors:  R J Hicks; M J Kelly; V Kalff
Journal:  Eur J Nucl Med       Date:  1990

2.  Characteristic cholescintigraphic images in space-occupying lesions.

Authors:  F Scopinaro; F Iorio; M Flammia; M Scarpini
Journal:  Eur J Nucl Med       Date:  1982

3.  Iodinated cholylglycyltyrosine: a new agent for hepatobiliary imaging.

Authors:  D Clements; C Mills; S Iqbal; S Chandler; E Elias
Journal:  Eur J Nucl Med       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.